CYMABAY THERAPEUTICS INC's ticker is CBAY and the CUSIP is 23257D103. A total of 142 filers reported holding CYMABAY THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.69 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $874,442 | +199.8% | 58,648 | +120.2% | 0.00% | – |
| Q2 2023 | $291,686 | -94.1% | 26,638 | -95.3% | 0.00% | -100.0% |
| Q1 2023 | $4,983,471 | +599.1% | 571,499 | +402.7% | 0.00% | – |
| Q4 2022 | $712,792 | +1727.7% | 113,683 | +910.2% | 0.00% | – |
| Q3 2022 | $39,000 | +8.3% | 11,253 | -8.2% | 0.00% | – |
| Q2 2022 | $36,000 | -45.5% | 12,252 | -18.8% | 0.00% | – |
| Q2 2021 | $66,000 | -73.7% | 15,085 | -72.7% | 0.00% | – |
| Q1 2021 | $251,000 | -73.9% | 55,332 | -67.0% | 0.00% | – |
| Q4 2020 | $962,000 | +63.3% | 167,563 | +106.0% | 0.00% | – |
| Q3 2020 | $589,000 | +280.0% | 81,344 | +3.1% | 0.00% | – |
| Q4 2019 | $155,000 | -64.2% | 78,903 | +141.9% | 0.00% | -100.0% |
| Q1 2019 | $433,000 | – | 32,623 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management IV, LLC | 2,023,369 | $27,154,000 | 9.26% |
| Omega Fund Management, LLC | 551,477 | $7,401,000 | 5.46% |
| Foresite Capital Management III, LLC | 1,562,040 | $20,963,000 | 4.51% |
| Versant Venture Management, LLC | 1,048,601 | $14,072,225,000 | 4.39% |
| Boxer Capital, LLC | 2,094,000 | $28,101,000 | 3.18% |
| Opaleye Management Inc. | 697,500 | $9,360,000 | 2.42% |
| Abingworth LLP | 273,417 | $3,667,000 | 2.10% |
| DAFNA Capital Management LLC | 294,511 | $3,952,000 | 1.85% |
| NEXTHERA CAPITAL LP | 828,655 | $11,121,000 | 1.72% |
| Vivo Capital, LLC | 906,000 | $12,158,000 | 1.57% |